Stay updated on AK104 Monotherapy Plus Axitinib in RCC Clinical Trial

Sign up to get notified when there's something new on the AK104 Monotherapy Plus Axitinib in RCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the AK104 Monotherapy Plus Axitinib in RCC Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.3%
    Check dated 2025-04-30T13:41:09.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    The web page has updated its version from v2.14.4 to v2.15.0, indicating a revision in the content. The phrase 'Here’s how you know' has been removed and replaced with the same phrase, suggesting a possible formatting or presentation change rather than a substantive content update.
    Difference
    1.0%
    Check dated 2025-04-16T01:03:42.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The web page has updated its version from v2.14.3 to v2.14.4, and a date has been added for March 6, 2025, while a date for March 25, 2025, has been removed.
    Difference
    0.7%
    Check dated 2025-04-08T19:31:10.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Summary
    The page has updated its status from 'Recruiting' to 'Active, not recruiting' and has changed the date from '2023-09-21' to '2025-03-06'.
    Difference
    2%
    Check dated 2025-03-10T20:43:33.000Z thumbnail image
  7. Check
    74 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    5%
    Check dated 2025-02-24T13:39:30.000Z thumbnail image
  8. Check
    88 days ago
    Change Detected
    Summary
    The page now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with a contact email for assistance.
    Difference
    6%
    Check dated 2025-02-10T08:55:16.000Z thumbnail image

Stay in the know with updates to AK104 Monotherapy Plus Axitinib in RCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the AK104 Monotherapy Plus Axitinib in RCC Clinical Trial page.